Antiphospholipid syndrome (APS) consists of thrombotic, non-thrombotic and obstetric
clinical manifestations developing in individuals with persistent antiphospholipid antibodies …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombotic and non-thrombotic macro-and microvascular manifestations and pregnancy …

Background Triple positivity for all 3 criteria antiphospholipid antibodies confers high risk of
symptom development in carriers, and recurrence in antiphospholipid syndrome (APS). Most …

Introduction Microvascular manifestations constitute a subtype of antiphospholipid
syndrome, and those patients have relatively poor prognoses, so it is important to find …

Antiphospholipid antibodies (aPLs) are the leading causes of adverse pregnancy outcomes
(APOs). We conducted cluster analysis to identify distinct phenotypes among aPLs …

Background β2-glycoprotein I (β2GPI) complexed with human leukocyte antigen DR
(β2GPI/HLA-DR) was found to be a major autoantibody target in antiphospholipid syndrome …

Background Antiphospholipid syndrome (APS) is a rare autoimmune disease characterized
by thromboses at various sites and obstetric events associated with the persistent presence …

Abstract Background The 2023 American College of Rheumatology (ACR)/European
League Against Rheumatism (EULAR) antiphospholipid syndrome (APS) classification …

Aim of the work To describe the clinical and laboratory characteristics of patients with
primary and secondary antiphospholipid syndrome (APS) in an Egyptian cohort. Patients …

Background. Pregnancy in systemic lupus erythematosus (SLE) patients is a challenge due
to the potential maternal and fetal complications. Therefore, a multidisciplinary assessment …